SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001062993-18-002283
Filing Date
2018-05-16
Accepted
2018-05-16 17:16:44
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM F-3 formf3.htm F-3 139660
2 EXHIBIT 5.1 exhibit5-1.htm EX-5.1 8560
3 EXHIBIT 23.1 exhibit23-1.htm EX-23.1 1874
4 GRAPHIC exhibit5-1x1x1.jpg GRAPHIC 5544
5 GRAPHIC exhibit5-1x1x2.jpg GRAPHIC 13756
6 GRAPHIC formf3x3x1.jpg GRAPHIC 3362
  Complete submission text file 0001062993-18-002283.txt   182683
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: F-3 | Act: 33 | File No.: 333-224983 | Film No.: 18840886
SIC: 2834 Pharmaceutical Preparations